Form4.ai tracks every SEC insider trade in real time. See every PTHS insider filing with a free account — no card.
See every PTHS insider filing — free account, no card.
Free accountPelthos Therapeutics Inc. (PTHS) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $45K. Most recent filing: Oct. 6, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 6, 2026 SEC filing | Friedberg Ezra M Director | Sold | $11,560 | — |
| Oct 6, 2026 SEC filing | Greenleaf Peter Director | Sold | $16,872 | — |
| Oct 6, 2026 SEC filing | Pauls Matthew Director | Sold | $16,506 | — |
Create a free account to see all 3 PTHS filings from the last 90 days. No card needed.
Create free accountWant PTHS insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.